2253-1556

ImmunoTargets and Therapy

Dove Medical Press

View prefix report (10.2147)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 353 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact353 DOIs
2

Attach ORCID iDs across 109 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact109 DOIs
3

Deposit reference lists for 95 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact95 DOIs

DOIs for this ISSN

Showing the top 5 of 352 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The role of adipokines in chronic inflammation (10.2147/itt.s73223)
Abstract References ORCID
188.99 330
2 The hygiene hypothesis: current perspectives and future ther… (10.2147/itt.s61528)
Abstract References ORCID
165.91 162
3 Clinical features, predictive correlates, and pathophysiolog… (10.2147/itt.s126227)
Abstract References ORCID
164.48 155
4 Safety of checkpoint inhibitors for cancer treatment: strate… (10.2147/itt.s141577)
Abstract References ORCID
153.98 112
5 The role of regulatory T cells in cancer immunology (10.2147/itt.s55415)
Abstract References ORCID
153.10 109
6 Toll-like receptors in the pathogenesis of autoimmune diseas… (10.2147/itt.s89795)
Abstract References ORCID
147.28 91
7 Current perspectives on the immunopathogenesis of systemic s… (10.2147/itt.s82037)
Abstract References ORCID
140.63 74
8 Melanoma treatment in review (10.2147/itt.s134842)
Abstract References
138.76 595
9 CD28 co-stimulation in T-cell homeostasis: a recent perspect… (10.2147/itt.s61647)
Abstract References ORCID
132.26 57
10 Insights into the pathogenesis of Langerhans cell histiocyto… (10.2147/itt.s91058)
Abstract References ORCID
131.69 56
11 Emerging roles for HMGB1 protein in immunity, inflammation,… (10.2147/itt.s58064)
Abstract References ORCID
128.70 51
12 Phase I clinical trial of sipuleucel-T combined with escalat… (10.2147/itt.s122497)
Abstract References ORCID
128.07 50
13 Review of checkpoint immunotherapy for the management of non… (10.2147/itt.s125070)
Abstract References ORCID
124.71 45
14 Cancer testis antigen and immunotherapy (10.2147/itt.s35570)
Abstract References ORCID
124.71 45
15 Cancer as an immune-mediated disease (10.2147/itt.s29834)
Abstract References ORCID
118.48 37
16 Current and emerging treatment options in the management of… (10.2147/itt.s40675)
Abstract References ORCID
117.62 36
17 <p>Bacillus Calmette-Guérin (BCG) Therapy for Bladder… (10.2147/itt.s202006)
Abstract References
113.00 181
18 Anti-amyloid-beta to tau-based immunization: developments in… (10.2147/itt.s31428)
Abstract References ORCID
112.89 31
19 <p>Cytokine Release Syndrome: Current Perspectives<… (10.2147/itt.s202015)
Abstract References
111.90 172
20 Targeting innate immunity to downmodulate adaptive immunity… (10.2147/itt.s117264)
Abstract References ORCID
107.35 26
21 Interplay Between Insulin Resistance and Immune Dysregulatio… (10.2147/itt.s499605)
Abstract References
107.31 139
22 First-line treatment of metastatic melanoma: role of nivolum… (10.2147/itt.s110479)
Abstract References ORCID
106.12 25
23 Hyaluronidase facilitated subcutaneous immunoglobulin in pri… (10.2147/itt.s31136)
Abstract References ORCID
106.12 25
24 Novel perspectives on non-canonical inflammasome activation (10.2147/itt.s57976)
Abstract References ORCID
103.52 23
25 Enhancement of antibody-dependent cell mediated cytotoxicity… (10.2147/itt.s61292)
Abstract References ORCID
103.52 23
26 Current perspective on the role of the interleukin-23/interl… (10.2147/itt.s62870)
Abstract References ORCID
99.17 20
27 Targeting myeloid-derived suppressor cells augments antitumo… (10.2147/itt.s32617)
Abstract References ORCID
97.58 19
28 The role of autophagy in microbial infection and immunity (10.2147/itt.s76720)
Abstract References ORCID
94.15 17
29 Pathophysiology of Non-IgE-Mediated Food Allergy (10.2147/itt.s284821)
Abstract ORCID
94.04 75
30 Multiple effects of CD40–CD40L axis in immunity ag… (10.2147/itt.s163614)
Abstract References
93.75 74
31 Current perspectives on natural killer cell education and to… (10.2147/itt.s61498)
Abstract References ORCID
90.31 15
32 Oncogenes in immune cells as potential therapeutic targets (10.2147/itt.s150586)
Abstract References ORCID
88.21 14
33 Metastatic renal cell carcinoma: update on epidemiology, gen… (10.2147/itt.s31426)
Abstract References ORCID
88.21 14
34 Immunotherapy for tuberculosis: future prospects (10.2147/itt.s81892)
Abstract References ORCID
88.21 14
35 Targeting CD22 for the Treatment of B-Cell Malignancies (10.2147/itt.s288546)
Abstract ORCID
87.41 55
36 <p>Varicella zoster virus vaccines: an update</p&gt… (10.2147/itt.s176383)
Abstract References
86.62 53
37 <p>Immunotherapy for Medulloblastoma: Current Perspect… (10.2147/itt.s198162)
Abstract ORCID
84.06 47
38 TNFR2: Role in Cancer Immunology and Immunotherapy (10.2147/itt.s255224)
Abstract ORCID
83.60 46
39 Clinical potential of apremilast in the treatment of psoriat… (10.2147/itt.s40199)
Abstract References ORCID
83.55 12
40 Antigen-based immunotherapy for autoimmune disease: current… (10.2147/itt.s49656)
Abstract References ORCID
83.55 12
41 Update on use of aldesleukin for treatment of high-risk meta… (10.2147/itt.s61590)
Abstract References ORCID
83.55 12
42 Antibody targeting of phosphatidylserine for the detection a… (10.2147/itt.s134834)
Abstract References
82.17 43
43 Anti-ghrelin antibodies in appetite suppression: recent adva… (10.2147/itt.s60398)
Abstract References ORCID
80.94 11
44 Prion diseases: immunotargets and therapy (10.2147/itt.s64795)
Abstract References ORCID
80.94 11
45 <p>Bruton’s Tyrosine Kinase Inhibitors: A New Therapeu… (10.2147/itt.s240874)
Abstract ORCID
80.64 40
46 <p>Gasdermin D Hypermethylation Inhibits Pyroptosis An… (10.2147/itt.s219867)
Abstract References
79.55 38
47 <p>All are Equal, Some are More Equal: Targeting IL 12… (10.2147/itt.s282466)
Abstract ORCID
78.41 36
48 <p>Immunochemotherapy for Richter syndrome: current in… (10.2147/itt.s167456)
Abstract References ORCID
78.10 10
49 Development of antibody-based c-Met inhibitors for targeted… (10.2147/itt.s37409)
Abstract References ORCID
78.10 10
50 Harnessing immunosurveillance: current developments and futu… (10.2147/itt.s37790)
Abstract References ORCID
78.10 10